The Clinton Health Access Initiative, Inc. (CHAI) is a global health organization committed to our mission of saving lives and reducing the burden of disease in low-and middle-income countries. We work at the invitation of governments to support them and the private sector to create and sustain high-quality health systems.
CHAI was founded in 2002 in response to the HIV/AIDS epidemic with the goal of dramatically reducing the price of life-saving drugs and increasing access to these medicines in the countries with the highest burden of the disease. Over the following two decades, CHAI has expanded its focus. Today, along with HIV, we work in conjunction with our partners to prevent and treat infectious diseases such as COVID-19, malaria, tuberculosis, and hepatitis. Our work has also expanded into cancer, diabetes, hypertension, and other non-communicable diseases, and we work to accelerate the rollout of lifesaving vaccines, reduce maternal and child mortality, combat chronic malnutrition, and increase access to assistive technology. We are investing in horizontal approaches to strengthen health systems through programs in human resources for health, digital health, and health financing. With each new and innovative program, our strategy is grounded in maximizing sustainable impact at scale, ensuring that governments lead the solutions, that programs are designed to scale nationally, and learnings are shared globally.
At CHAI, our people are our greatest asset, and none of this work would be possible without their talent, time, dedication and passion for our mission and values. We are a highly diverse team of enthusiastic individuals across 40 countries with a broad range of skillsets and life experiences. CHAI is deeply grounded in the countries we work in, with majority of our staff based in program countries. Learn more about our exciting work: http://www.clintonhealthaccess.org
CHAI is an Equal Opportunity Employer, and is committed to providing an environment of fairness, and mutual respect where all applicants have access to equal employment opportunities. CHAI values diversity and inclusion, and recognizes that our mission is best advanced by the leadership and contributions of people with diverse experience, backgrounds, and culture.
CHAI launched the COVID-19 Treatment Access (CTA) program in August 2022 with the goal of reducing the impact of COVID-19 on high-risk individuals. Through the scale-up of screening programs and the introduction of novel oral antiviral therapies in low- and middle-income countries (LMICs), CHAI seeks to greatly reduce hospitalization and mortality in the populations at the highest risk for progression to severe and critical disease. The COVID Treatment Access team currently supports programs in Sub-Saharan Africa (Kenya, Uganda, Nigeria, Ghana, Rwanda, Malawi, Zimbabwe, Zambia, Republic of South Africa) and Southeast Asia (Laos) with plans to expand to additional countries across both regions in the coming months. The program will focus supporting ministries of health to implement smart, data-driven strategies for identifying COVID-positive individuals at high risk for severe and critical disease, while in parallel ensuring critical access to life-saving treatment commodities within health facilities. In addition, the program will support countries to integrate critical COVID-19 services into the broader health system to ensure sustained access to services. In focal countries, CHAI’s work ranges depending on the specific context and need, and work can include a range of activities, including providing support on procurement, training health care workers, developing monitoring and evaluation systems, and supporting site-level implementation.
Position Overview:
As part of the Global COVID-19 Treatment Access Country Support team, this Associate will support the implementation and scale-up of CHAI’s COVID-19 country programs in Sub-Saharan Africa (SSA). The Associate will support CHAI programs in countries as they begin to scale COVID Treatment Access programs, helping to develop efficient programs which catalyze the scale-up of testing activities, linkage to treatment, and treatment initiation. The Associate will provide support on a wide-range of activities, including providing strategic guidance and planning support, developing programmatic tools to support the roll-out and scale up of programs, providing coordination support across global and country programs, and supporting cross-cutting global work streams, projects, and communications. The Associate will report to the Global COVID-19 Treatment Access Program Manager.
To support this work, we are seeking a highly motivated individual with outstanding credentials, strong analytical abilities, and superior problem-solving and communication skills. The candidate must be self-driven, resourceful, collaborative, adaptable and have a high level of comfort with ambiguity. The candidate should have experience working in fast-paced, multi-cultural environments and is expected to function independently with minimal guidance.
The base location is flexible, with a strong preference for a CHAI CTA program in Sub-Saharan Africa, pending Country Director Approval. Expected travel is 30%.
Provide strategic, technical, and planning support and bandwidth to country programs (60%):
Provide coordination support across global and country programs (25%):
Support cross-cutting global work streams, projects, and communications (15%):
Advantages:
#jobreference2 #region3
Software Powered by iCIMS
www.icims.com